vorinostat
vorinostat is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including ZOLINZA. Available dosage form: capsule.
Drug Details
- Generic Name
- vorinostat
- Brand Names
- ZOLINZA
- Application Number
- NDA021991
- Sponsor
- Merck Sharp & Dohme LLC
- NDC Codes
- 2
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- VORINOSTAT
Indications and Usage
1 INDICATIONS AND USAGE ZOLINZA ® is indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease on or following two systemic therapies. ZOLINZA is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma (CTCL) who have progressive, persistent or recurrent disease on or following two systemic therapies. ( 1 )